| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |